Avedro, Inc. Announces Third Quarter 2019 Financial Results
November 06, 2019 08:30 ET
|
Avedro, Inc
WALTHAM, Mass., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today reported financial results for the quarter ended September 30, 2019. Third Quarter Financial...
Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting
October 09, 2019 16:30 ET
|
Avedro, Inc
WALTHAM, Mass., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced its schedule of scientific and educational programs focused on corneal cross-linking and...
Boost Epi-On™ Corneal Cross-Linking Data to Be Presented at the 37th Congress of the ESCRS
September 11, 2019 16:30 ET
|
Avedro, Inc
WALTHAM, Mass., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced the inclusion of a wide array of Boost Epi-On cross-linking (CXL) presentations in the...
Avedro, Inc. Announces Second Quarter 2019 Financial Results
August 07, 2019 16:15 ET
|
Avedro, Inc
Updates Full Year 2019 Revenue Guidance Earnings Call and Webcast Previously Scheduled for Tomorrow, Thursday, August 8 Will Now Occur Today, Wednesday, August 7 at 4:30 p.m. ET as a joint call with...
Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019
July 25, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced that it will release financial results for the second quarter of 2019 after the close of...
Avedro, Inc. to Present at the Guggenheim MedTech Disruptors Summit
May 20, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Guggenheim MedTech Disruptors Summit in New...
Avedro, Inc. Announces First Quarter 2019 Financial Results
May 09, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today reported financial results for the quarter ended March 31, 2019. Recent Highlights First quarter...
Avedro Completes Enrollment in Pivotal U.S. Phase 3 Epi-On Corneal Cross-Linking Clinical Trial for Progressive Keratoconus
May 01, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro), today announced that the company has completed patient enrollment in a pivotal Phase 3 clinical trial to...
Avedro, Inc. to Present at the Bank of America Merrill Lynch Health Care Conference
April 30, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., April 30, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (“Avedro”), today announced the company will be participating in the upcoming Bank of America Merrill Lynch Health Care...
Avedro Announces Comprehensive Educational Schedule at ASCRS Annual Meeting
April 29, 2019 16:05 ET
|
Avedro, Inc
WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc. (Nasdaq: AVDR) (Avedro) today announced the inclusion of a wide range of corneal cross-linking and keratoconus scientific and...